Klingelnberg AG

BATS-CHIXE:KLINZ Stock Report

Market Cap: CHF 119.3m

Klingelnberg Future Growth

Future criteria checks 2/6

Klingelnberg is forecast to grow earnings and revenue by 12.9% and 4.5% per annum respectively while EPS is expected to grow by 12.4% per annum.

Key information

12.9%

Earnings growth rate

12.4%

EPS growth rate

Machinery earnings growth14.2%
Revenue growth rate4.5%
Future return on equityn/a
Analyst coverage

Low

Last updated19 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:KLINZ - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202736421N/AN/A1
3/31/202635119N/AN/A1
3/31/202533418N/AN/A1
9/30/202432614-37N/A
6/30/202431516615N/A
3/31/2024303171523N/A
12/31/2023290201322N/A
9/30/2023276231021N/A
6/30/202329222418N/A
3/31/202330921-316N/A
12/31/202227520-23-3N/A
9/30/202224220-43-22N/A
6/30/2022200-1-54-38N/A
3/31/2022159-22-66-55N/A
12/31/2021155-30-41-33N/A
9/30/2021152-39-15-12N/A
6/30/2021155-23-6-2N/A
3/31/2021159-748N/A
12/31/2020172-18712N/A
9/30/2020185-281116N/A
6/30/2020199-2727N/A
3/31/2020212-25-8-2N/A
12/31/2019240-5-33N/A
9/30/20192681628N/A
6/30/2019273181118N/A
3/31/2019278192028N/A
12/31/2018279171623N/A
9/30/2018280151217N/A
6/30/201826814N/A12N/A
3/31/201825714N/A6N/A
3/31/201723111N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: KLINZ's forecast earnings growth (12.9% per year) is above the savings rate (2.1%).

Earnings vs Market: KLINZ's earnings (12.9% per year) are forecast to grow slower than the UK market (14.6% per year).

High Growth Earnings: KLINZ's earnings are forecast to grow, but not significantly.

Revenue vs Market: KLINZ's revenue (4.5% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: KLINZ's revenue (4.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if KLINZ's Return on Equity is forecast to be high in 3 years time


Discover growth companies